Synageva files $150 million shelf covering preferreds, stock, debt

By Devika Patel

Knoxville, Tenn., May 23 - Synageva Biopharma Corp. filed a $150 million shelf registration in an S-3 filing with the Securities and Exchange Commission. The amount includes $10 million of previously registered but unsold securities.

The registration covers common stock, preferred stock, warrants and debt securities.

The securities may be structured as convertibles.

Proceeds will be used for general corporate purposes.

The clinical-stage biopharmaceutical company is based in Morrisville, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.